(02) 6620 1800 [email protected]

Biogen has released a white paper looking at the future impact of Alzheimer’s disease and ways to manage the disease.

Biogen is an American multinational biotechnology company based in Cambridge, Massachusetts, specialising in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Their report can be downloaded here

Click here for report